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women (1.5% of the population). Women were more likely to have a positive 
initial stress test, 19% versus 12% of men (p < 0.05). 
For utilization (prevalence), the age adjusted rates were mmkedly higher 
for men (2081 per 100,000) than for women (726 per 100,000) and the age- 
adjusted rate ratio was 2.9. The utilization rates pe~ed at ages 60-69 for 
both genders with a rate ratio of 2.5. 
These population-based ata show that, when they have an first stress 
test, women are older, have worse baseline characteristics and are more 
likely to have a positive test. In addition, the utilization of stress testing is 
lower in women. Whether these obsen~etions can solely be attributed to 
differences in disease prevalence remains uncertain particulady for older 
age groups and needs further studies. 
9"8"2--~1 Influence of A Critical Pathway to Maximize Same 
Day Sheath Pulling on An Intsrventional Cardiology 
Ser~']cc: !replications for Length of Stay and 
Complicatio~$ 
Eva Kline, David W. Muller, Stevan W. Warns, Mauro Moscucci, Dean 
J. Karavite, Eric R. Bates, Kim A. Eagle. University of Michigan Heart Care 
Program, Ann Arbor, MI 
In order to evaluate the impact of a critical pathway on process of care 
and outcomes following percutanecus comcaP/interventions, we studied 
257 patients (PTS) undergoing balloon PTCA, coronary atherecfomy, and 
corena~y slant placement (and combinations) from January 1 through June 
30, 1994. The critical pathway case coordinator identified potential candi- 
dates for same-day sheath pull, provided feedback to faculty and fellows 
regarding pathway variances, and tracked bleeding (BLEED) complications 
(hemetoma, need for transfusion or retroperitoneal bfesd) prospectively. 
Study period was divided into three separate two-month blocks. Outcomes 
were assessed for each period and included % of patients having same day 
sheath pull, eligible but not having same day pull, discharged within 48 hours 
(LOS < 48 hrs), and % of PTS having BLEED. The % of PTS having same 
day sheath pull was 41%, 51%, and 51% for the 3 pedods, wh,e the % of 
PT$ eligible but not having same day pull Vended downward from 28% to 
16.6%, to 18.5% (P = N$). 
Jan-Feb Mar-Apr June-July P-Value 
(n=83) (n = 102) (n=S2) 
% PTS LOS < 48 hrs 54% 62% 70% P = 0.04 
% PTS BLEED 26% 14.7% 11.9% P = 0.02 
Conclusion: Use of a critical pathway to monitor complications and maxi- 
mize same day sheath pull for short stay PTCA patients was associated with 
a higher % of early discharge and lowering of bleeding complications. Over- 
all mortality, MI, and repeat anglography were infrequent and comparable 
during the study periods. 
~ ' ~  Predlcters o f  Early Discharge After Cardiac Surgery 
and Its Cost-Effect iveness 
Nancy J. Nickerson, Susan R Murphy, Nicholas T, Kouchoukos, Bill B. Daily, 
Kenneth B. Schechtman, Victor G. D~vila-Rom~n. Washington University 
School of Medidneo St. Louis, MO 
There are limited data on the predictors and cost-effectiveness of decreasing 
postoperative length of stay (LOS) after cardiac surgery. We evaluated an 
Early Discharge lED) protocol that consisted of modifying anesthesia, limiting 
the use of postoperative narcotics, esdy extubaUon and mob,lzation, and 
hospital discharge at < 5 days. ED criteria included hemodynamlc stability, 
nomlai bowel function, independence in activities of daily living, and the 
absence of fever and incisionai problems. This approach was prospectively 
applied In 422 consecutive patients (age range 15-89 years, 65%0 men): 
CABG (n ,= 290), valve procedures (n ,, 54), or CABG + valve pmcadures (n 
,, 78). Early extubation (_< 10 hrs) was achieved in 43%, and 47% had ICU 
stay < 24 hours. ED was achieved in 33% of the entire group. Predictors of 
Early vs Late Dischargo (muifivariete analysis): 
<_. 5 days > 5 days p value 
Increasing age (years) 61.3 66.8 0.016 
Left venfficulsr dysfunclion* 8,4 9.6 0.02 
CABG + valve (%) 6.5 24.3 0.005 
Female gender (%) 21.7 41.5 0.0006 
Atrial fibrillation (%) 13.0 32.4 0.001 
*CASS left ventricular wall motion score 
The 30 day mortality for the entire group was 3,2%. The 30 day readmisslon 
rate for the ED group was 7.8% vs 16,2% for the late discharge group (p = 
0.01). To assess the cost-effectiveness of this approach, DRGs 106 & 107 
were compared for the 1st quarter of the year ED was implemented (1995) 
and the 1st quarter of the previous year (lgg4). There was an overall cost- 
reduction of $4,500/pt and $1,400/pt, and a decrease in LOS of 2,5 and 1.0 
days, respectively. Thus, decreased postoperative LOS can be accomplished 
safely in the cardiac surgical population and is associated with d~..mased 
cost. 
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9~-~'1  Long-Term Performance of Pace-Sense Lead 
Systems for Implantsble Cardioverters 
Linette Ktsvan, Ma;'tha Tenzer, Robert Bemstein, Lenox Baker, 
Szabolcs Szentpetery, Jeffrey Rich, John M. Herre. Eastern Virginia Medical 
School, SanPara Norfolk General Hospital, Norfolk, VA 
With increasing sophistication of Imptantable cardioverter detibrilletore (ICDs), 
long term intngdty of the sense-pace lead system has become more impor- 
tant. We evaluated pace-sense lead systems in 457 patients (pts). Paca- 
sense lead systems were replaced for oversenaing, lead fracture, failure to 
detect or redetect ventdcular f~rilletlon and inability to pace. Pace-sense 
lead systems were replaced aiectivety at time of pulse generator (PG) m- 
placement if R < 3.0 mV or pacing threshold • 2.5 V. Pts were 77.5% male, 
ages 16 to 90. Ejection fraction was 0.34 ± 0.15 (mean ~ S.D.) and 62.6% 
o! pts had CAD. 
n Months 
6 12 24 38 48 
Pace-sense lead survival 
Pace-sense-defibdllate 
CPI Endotak 231 0.97 0.97 0.85 0.88 0.81 
Medlronic Transvene 39 1.0 1.0 + + + 
Ventritex TVL 14 1 .O 1.0 + + + 
Bipolar t'ransvenous pace-sense 67 0.97 0.95 0.89 0.82 0.76 
Eplcerdial screw-in pace-sense 106 1.0 1.0 0.91 0.82 0.71 
Overallptsurvival 457 0.94 0.92 0.87 0.83 0.79 
+Insufficient data 
Conclusions: Pace-sense lead problems can be expected in 20-30% of 
ICD pts at 4 years with a vend toward better long-term performance with 
tTansvenous pace-sense-defibrillete l ads. Replacement of epicerdiai paca- 
sense leads should be considered at PG replacement. 
J '~ ' -3"~ Defibri l lation Eff icacy o f  Dif ferent Defibri l lator 
Case Sizes In Patients: How Smal l  Is Too Small? 
Andrea Nataie, Margaret M. Keamey, M. Joan Brandon, Virgini~ Kent, 
Eric Fain, Keith H. New'oy. VA Medical Canter~Duke University, Durham, NC 
The use of prophylactic cardtoverter-defibd,ator implantation could be lim- 
ited by the size of current devices. The single lead unlpolar system could 
represent on attractive technology for this use if a small size can maintains a 
deflbd,ation efflcaw similar to larger sizes. We tested the defibdllation suc- 
cess of a 73 co, 40 co, and 16 co defibrillator cans in 10 consecutive patients 
undergoing defibrillator implant. In each patient, all 3 sizes were tested in 
randomized order. Blphasic shocks were delivered using the external defib- 
rillator HV$/O2. The mean energy (joules) and peak voltage at defibrillation 
threshold are shown: 
73cc 40cc 16c¢ 
Energy 12.5 -4- 4.3 12.9 ± B.0 13.2 • 5.8 
Vol!age 441 ±803 445~ 110 451 ±94 
p = NS for all comparisons 
Conclusions: even a can volume of 16 cc does not affect he defibrillation 
efficacy of the single lead unlpolar system. A defibrillator of this size will 
certainly be more acceptable for prophylactic use and appears to be feasible. 
Autonomic Nervous Dysfunction in Patients With 
Implanted Defibrillator 
Christeph Ehlere, Dietrich A~lresen, Bettina Wiederkehr, 
Thomas Br0ggemann, Wolfgang Ziss, Heinz-R Schutthai8. Dpt. Cardiology, 
Benjamin Frank~in Medical Center, Free University of Bedin, Germany 
Nonlnvasive cardiovascular reflex tests, performed to assess for cardiac 
autonomic nervous dysfunction, have shown to predict clinical outcome in 
